Meanwhile, the DCs cells may be unable to valid stimulate T activation due to the decreased expression of CD86 and unbalanced CD80/CD86 ratio in DN-CML patients (Figure 5). Here, CD86 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.